Milestone Pharmaceuticals Inc
MIST
Get informed when a big investor buys or sells
+ FollowMarket Cap$111.66M
Close$
$0.17
87.2% downside
Current Fair Value
87.2% downsideOvervalued by 87.2% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $111.66 Million |
|---|---|
| Enterprise Value | $178.08 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.75 |
| Beta | 0.97 |
| Outstanding Shares | 130,286,033 |
Return
| Return on Equity | -201.83% |
|---|---|
| Return on Assets | -37.56% |
| Return on Invested Capital | -31.94% |
Valuation & Multiples
| P/E Ratio | -2.48 |
|---|---|
| PEG | - |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 106.38 |
| Enterprise Value to EBIT | -3.23 |
| Enterprise Value to Net Income | -3 |
| Total Debt to Enterprise | 0.77 |
| Debt to Equity | 3.82 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 18, 2026
EPS Estimate
$0.10
Average shareholder expectationRevenue Estimate
$37.54 M
Average shareholder expectationNext Earnings Call
Expected Date
August 11, 2026
EPS Estimate
$-0.21
Average shareholder expectationRevenue Estimate
$1.01 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 7.3085▲ 243.70% |
|---|---|
| Total Calls | 36,300▼ 79.19% |
| Total Puts | 265,300▼ 68.77% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 35.52%▼ 4.39% |
|---|---|
| Total Invested | $35.64M▼ 33.47% |
| Investors Holding | 89▲ 3.00% |
ESG Score
No data